Pharmaceutical Sciences
Global

Pharmaceutical Sciences Experts

Reginald Hardy


Pharma
BioCancell Therapeutics 
Israel

Biography

Mr. Hardy is the co-founder and CEO of Brickell Biotech, Inc., a pharmaceutical company focused on developing novel drugs for the treatment of skin diseases. Prior to Brickell, he was the co-founder and President of Concordia Pharmaceuticals, Inc. an oncology drug development company acquired by Kadmon Corporation in 2011. From 1992 to 1998, he was President of SANO Corporation, a pharmaceutical company that he co-founded, focused on the development of novel transdermal drug delivery systems that was acquired by Elan Corporation in 1998. Prior to SANO, Mr. Hardy held various corporate roles with IVAX Corporation, Key Pharmaceuticals, and Hoechst-Roussel Pharmaceuticals, Inc. He earned his B.S. degree in Pharmacy from the University of North Carolina – Chapel Hill and M.B.A. from UNC – Greensboro.  

Research Interest

Pharma

Global Experts from Israel

Global Experts in Subject

Share This Profile